Altered chemokine receptor expression in papillary thyroid cancer

Thyroid

Volumn 19, Issue 9, 2009, Pages 957-965

  González, Hernán E ^a,b   Leiva, Andrea ^a,c   Tobar, Hugo ^a,c   Böhmwald, Karen ^a,c   Tapia, Grace ^b   Torres, Javiera ^b   Mosso, Lorena M ^b   Bueno, Susan M ^b   Gonzalez, Pablo ^b   Kalergis, Alexis M ^a,b   Riedel, Claudia A ^a,c  

^a Faculty of Biological Sciences   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER;

ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECEPTORS, CCR3; RECEPTORS, CCR7; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; THYROID GLAND; THYROID NEOPLASMS;

EID: 70349117750     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0432     Document Type: Article

References (44)

1. American Cancer Society 2008 Cancer Facts & Figures. Atlanta, GA: American Cancer Society.
2. Nikiforov YE 2008 Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 21 Suppl 2:S37-S43.
3. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS 2009 Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 18:784-791.
4. Leenhardt L, Grosclaude P, Cherie-Challine L 2004 Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056-1060.
5. Arai T, Yamashita T, Urano T, Masunaga A, Itoyama S, Itoh K, Shiku H, Sugawara I 1995 Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid. Mod Pathol 8:252-256.
6. Noguchi S, Noguchi A, Murakami N 1970 Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision. Cancer 26:1061-1064.
7. Noguchi S, Noguchi A, Murakami N 1970 Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26:1053-1060.
8. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463.
9. Rossi RL, Cady B, Silverman ML, Wool MS, Horner TA 1986 Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 10:612-622.
10. Samaan NA, Maheshwari YK, Nader S, Hill CS Jr., Schultz PN, Haynie TP, Hickey RC, Clark RL, Goepfert H, Ibanez ML, Litton CE 1983 Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 56:1131-1138.
11. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C 1985 Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794-804. (Pubitemid 15173518)
12. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A 2001 Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
13. Baggiolini M 2001 Chemokines in pathology and medicine. J Intern Med 250:91-104.
14. Frederick MJ, Clayman GL 2001 Chemokines in cancer. Expert Rev Mol Med 3:1-18.
15. Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS 2003 Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89:462-473.
16. Kato M, Kitayama J, Kazama S, Nagawa H 2003 Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5:R144-R150.
17. Raman D, Baugher PJ, Thu YM, Richmond A 2007 Role of chemokines in tumor growth. Cancer Lett 256:137-165.
18. Matsukawa A, Lukacs NW, Hogaboam CM, Chensue SW, Kunkel SL 2001 III. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung. Microsc Res Tech 53:298-306.
19. Balkwill F 2004 Cancer and the chemokine network. Nat Rev Cancer 4:540-550.
20. Beider K, Abraham M, Peled A 2008 Chemokines and che-mokine receptors in stem cell circulation. Front Biosci 13: 6820-6833.
21. Rossi D, Zlotnik A 2000 The biology of chemokines and their receptors. Annu Rev Immunol 18:217-242.
22. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA 2000 International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176.
23. Baggiolini M 1998 Chemokines and leukocyte traffic. Nature 392:565-568.
24. Allen SJ, Crown SE, Handel TM 2007 Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787-820.
25. Neel NF, Schutyser E, Sai J, Fan GH, Richmond A 2005 Chemokine receptor internalization and intracellular traf-ficking. Cytokine Growth Factor Rev 16:637-658.
26. Locati M, Deuschle U, Massardi ML, Martinez FO, Sironi M, Sozzani S, Bartfai T, Mantovani A 2002 Analysis of the gene expression profile activated by the CC chemokine ligand 5=RANTES and by lipopolysaccharide in human monocytes. J Immunol 168:3557-3562.
27. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO, Hwang ST 2002 Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62:7328-7334.
28. Cardones AR, Murakami T, Hwang ST 2003 CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res 63:6751-6757.
29. Takanami I 2003 Overexpression of CCR7 mRNA in non-small cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105:186-189.
30. Wang J, Xi L, Hunt JL, Gooding W, Whiteside TL, Chen Z, Godfrey TE, Ferris RL 2004 Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 64:1861-1866.
31. Sancho M, Vieira J, Casalou C, Mesquita M, Pereira T, Cavaco BM, Dias S, Leite V 2006 Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. J Endocrinol 191:229-238.
32. Yasuoka H, Kodama R, Hirokawa M, Takamura Y, Miyauchi A, Sanke T, Nakamura Y 2008 CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis. BMC Cancer 8:274.
33. Wagner PL, Moo TA, Arora N, Liu YF, Zarnegar R, Scog-namiglio T, Fahey TJ III 2008 The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Ann Surg Oncol 15:2833-2841.
34. Johrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Holtl L, Bartsch G, Greil R, Thurnher M 2005 Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma. Clin Cancer Res 11:2459-2465.
35. Kouno J, Nagai H, Nagahata T, Onda M, Yamaguchi H, Adachi K, Takahashi H, Teramoto A, Emi M 2004 Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth. J Neurooncol 70:301-307.
36. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S 1997 Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80:2268-2272.
37. Yamashita H, Noguchi S, Murakami N, Toda M, Uchino S, Watanabe S, Kawamoto H 1999 Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid micro-carcinoma. Cancer 86:842-849.
38. Sugasawa H, Ichikura T, Tsujimoto H, Kinoshita M, Morita D, Ono S, Chochi K, Tsuda H, Seki S, Mochizuki H 2008 Prognostic significance of expression of CCL5=RANTES receptors in patients with gastric cancer. J Surg Oncol 97: 445-450.
39. Sancho M, Vieira JM, Casalou C, Mesquita M, Pereira T, Cavaco BM, Dias S, Leite V 2006 Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. J Endocrinol 191:229-238.
40. Kleinhans M, Tun-Kyi A, Gilliet M, Kadin ME, Dummer R, Burg G, Nestle FO 2003 Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 101:1487-1493.
41. New DC, Wong YH 2003 CC chemokine receptor-coupled signalling pathways. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35:779-788.
42. Zimmermann N, Conkright JJ, Rothenberg ME 1999 CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem 274:12611-12618.
43. Beaulieu S, Robbiani DF, Du X, Rodrigues E, Ignatius R, Wei Y, Ponath P, Young JW, Pope M, Steinman RM, Mojsov S 2002 Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells. J Im-munol 169:2925-2936.
44. Forster R, Kremmer E, Schubel A, Breitfeld D, Klein-schmidt A, Nerl C, Bernhardt G, Lipp M 1998 Intracellular and surface expression of the HIV-1 coreceptor CXCR4=fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J Immunol 160:1522-1531.